Literature DB >> 17023000

DBC2 is essential for transporting vesicular stomatitis virus glycoprotein.

Faith K Chang1, Noriko Sato, Noriko Kobayashi-Simorowski, Takashi Yoshihara, Jennifer L Meth, Masaaki Hamaguchi.   

Abstract

DBC2 is a tumor suppressor gene linked to breast and lung cancers. Although DBC2 belongs to the RHO GTPase family, it has a unique structure that contains a Broad-Complex/Tramtrack/Bric a Brac (BTB) domain at the C terminus instead of a typical CAAX motif. A limited number of functional studies on DBC2 have indicated its participation in diverse cellular activities, such as ubiquitination, cell-cycle control, cytoskeleton organization and protein transport. In this study, the role of DBC2 in protein transport was analyzed using vesicular stomatitis virus glycoprotein (VSVG) fused with green fluorescent protein. We discovered that DBC2 knockdown hinders the VSVG transport system in 293 cells. Previous studies have demonstrated that VSVG is transported via the microtubule motor complex. We demonstrate that DBC2 mobility depends also on an intact microtubule network. We conclude that DBC2 plays an essential role in microtubule-mediated VSVG transport from the endoplasmic reticulum to the Golgi apparatus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17023000      PMCID: PMC1713265          DOI: 10.1016/j.jmb.2006.09.026

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  19 in total

Review 1.  The BACK domain in BTB-kelch proteins.

Authors:  Peter J Stogios; Gilbert G Privé
Journal:  Trends Biochem Sci       Date:  2004-12       Impact factor: 13.807

2.  DBC2 significantly influences cell-cycle, apoptosis, cytoskeleton and membrane-trafficking pathways.

Authors:  Veeraiah Siripurapu; Jennifer Meth; Noriko Kobayashi; Masaaki Hamaguchi
Journal:  J Mol Biol       Date:  2004-12-08       Impact factor: 5.469

Review 3.  The Ras superfamily at a glance.

Authors:  Krister Wennerberg; Kent L Rossman; Channing J Der
Journal:  J Cell Sci       Date:  2005-03-01       Impact factor: 5.285

Review 4.  Function and regulation of Rnd proteins.

Authors:  Pierre Chardin
Journal:  Nat Rev Mol Cell Biol       Date:  2006-01       Impact factor: 94.444

5.  Golgi membrane dynamics.

Authors:  J F Presley; C Smith; K Hirschberg; C Miller; N B Cole; K J Zaal; J Lippincott-Schwartz
Journal:  Mol Biol Cell       Date:  1998-07       Impact factor: 4.138

6.  A genetic screen for suppressors of Drosophila NSF2 neuromuscular junction overgrowth.

Authors:  Matthew J Laviolette; Paula Nunes; Jean-Baptiste Peyre; Toshiro Aigaki; Bryan A Stewart
Journal:  Genetics       Date:  2005-04-16       Impact factor: 4.562

7.  ER-to-Golgi transport visualized in living cells.

Authors:  J F Presley; N B Cole; T A Schroer; K Hirschberg; K J Zaal; J Lippincott-Schwartz
Journal:  Nature       Date:  1997-09-04       Impact factor: 49.962

8.  RhoBTB2 is a substrate of the mammalian Cul3 ubiquitin ligase complex.

Authors:  Andrew Wilkins; Qinggong Ping; Christopher L Carpenter
Journal:  Genes Dev       Date:  2004-04-15       Impact factor: 11.361

9.  Kinetic analysis of secretory protein traffic and characterization of golgi to plasma membrane transport intermediates in living cells.

Authors:  K Hirschberg; C M Miller; J Ellenberg; J F Presley; E D Siggia; R D Phair; J Lippincott-Schwartz
Journal:  J Cell Biol       Date:  1998-12-14       Impact factor: 10.539

10.  The PROSITE database.

Authors:  Nicolas Hulo; Amos Bairoch; Virginie Bulliard; Lorenzo Cerutti; Edouard De Castro; Petra S Langendijk-Genevaux; Marco Pagni; Christian J A Sigrist
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

View more
  16 in total

Review 1.  A CULLINary ride across the secretory pathway: more than just secretion.

Authors:  Albert Lu; Suzanne R Pfeffer
Journal:  Trends Cell Biol       Date:  2014-03-11       Impact factor: 20.808

2.  Structural basis of selective ubiquitination of TRF1 by SCFFbx4.

Authors:  Zhixiong Zeng; Wei Wang; Yuting Yang; Yong Chen; Xiaomei Yang; J Alan Diehl; Xuedong Liu; Ming Lei
Journal:  Dev Cell       Date:  2010-02-16       Impact factor: 12.270

Review 3.  Rho GTPases: Regulation and roles in cancer cell biology.

Authors:  Raquel B Haga; Anne J Ridley
Journal:  Small GTPases       Date:  2016-09-14

4.  RhoBTB3: a Rho GTPase-family ATPase required for endosome to Golgi transport.

Authors:  Eric J Espinosa; Monica Calero; Khambhampaty Sridevi; Suzanne R Pfeffer
Journal:  Cell       Date:  2009-05-29       Impact factor: 41.582

5.  Characterization of RhoBTB-dependent Cul3 ubiquitin ligase complexes--evidence for an autoregulatory mechanism.

Authors:  Jessica Berthold; Kristína Schenková; Sonia Ramos; Yoshie Miura; Manabu Furukawa; Pontus Aspenström; Francisco Rivero
Journal:  Exp Cell Res       Date:  2008-09-20       Impact factor: 3.905

6.  DBC2 resistance is achieved by enhancing 26S proteasome-mediated protein degradation.

Authors:  Denise Collado; Takashi Yoshihara; Masaaki Hamaguchi
Journal:  Biochem Biophys Res Commun       Date:  2007-07-02       Impact factor: 3.575

7.  Cyclin D1 down-regulation is essential for DBC2's tumor suppressor function.

Authors:  Takashi Yoshihara; Denise Collado; Masaaki Hamaguchi
Journal:  Biochem Biophys Res Commun       Date:  2007-05-15       Impact factor: 3.575

Review 8.  The pseudoGTPase group of pseudoenzymes.

Authors:  Amy L Stiegler; Titus J Boggon
Journal:  FEBS J       Date:  2020-09-17       Impact factor: 5.542

9.  Evaluation of Methylation Status in the 5'UTR Promoter Region of the DBC2 Gene as a Biomarker in Sporadic Breast Cancer.

Authors:  Mehri Hajikhan Mirzaei; Mehrdad Noruzinia; Hamid Karbassian; Yousef Shafeghati; Mousa Keyhanee; Ali Bidmeshki-Pour
Journal:  Cell J       Date:  2012-06-13       Impact factor: 2.479

10.  Identification of RHOBTB2 aberration as an independent prognostic indicator in acute myeloid leukemia.

Authors:  Peng Liu; Qinghai Ma; Hanxiang Chen; Li Zhang; Xiaoning Zhang
Journal:  Aging (Albany NY)       Date:  2021-06-01       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.